Christopher McCabe
Christopher McCabe
Executive Director and CEO, Institute of Health Economics, Alberta
Verified email at
Cited by
Cited by
ISPOR Task Force on Good Research Practices--Modeling Studies. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task …
MC Weinstein, B O’Brien, J Hornberger, J Jackson, M Johannesson, ...
Value Health 6 (1), 9-17, 2003
The NICE cost-effectiveness threshold
C McCabe, K Claxton, AJ Culyer
Pharmacoeconomics 26 (9), 733-744, 2008
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
K Claxton, M Sculpher, C McCabe, A Briggs, R Akehurst, M Buxton, ...
Health economics 14 (4), 339-347, 2005
Whither trial‐based economic evaluation for health care decision making?
MJ Sculpher, K Claxton, M Drummond, C McCabe
Health economics 15 (7), 677-687, 2006
Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation
UK Neonatal Staffing Study Group
The Lancet 359 (9301), 99-107, 2002
Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
RJ Pollitt, A Green, CJ McCabe, A Booth, NJ Cooper, JV Leonard, ...
Health technology assessment (Winchester, England) 1 (7), i-iv, 1, 1997
Evaluation of a diabetic foot screening and protection programme
CJ McCabe, RC Stevenson, AM Dolan
Diabetic Medicine 15 (1), 80-84, 1998
An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative …
FJ Collinson, DG Jayne, A Pigazzi, C Tsang, JM Barrie, R Edlin, C Garbett, ...
International journal of colorectal disease 27 (2), 233-241, 2012
Measuring the mental health status of a population: A comparison of the GHQ–12 and the SF–36 (MHI–5)
CJ McCabe, KJ Thomas, JE Brazier, P Coleman
The British Journal of Psychiatry 169 (4), 517-521, 1996
Orphan drugs and the NHS: should we value rarity?
C McCabe, K Claxton, A Tsuchiya
Bmj 331 (7523), 1016-1019, 2005
Value based pricing for NHS drugs: an opportunity not to be missed?
K Claxton, A Briggs, MJ Buxton, AJ Culyer, C McCabe, S Walker, ...
Bmj 336 (7638), 251-254, 2008
Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence
A Culyer, C McCabe, A Briggs, K Claxton, M Buxton, R Akehurst, ...
Journal of health services research & policy 12 (1), 56-58, 2007
Should patients have a greater role in valuing health states?
J Brazier, R Akehurst, A Brennan, P Dolan, K Claxton, C McCabe, ...
Applied health economics and health policy 4 (4), 201-208, 2005
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review
M Connock, A Burls, E Frew, A Fry-Smith, A Juarez-Garcia, C McCabe, ...
University of Leicester, 2006
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
HM Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ...
The Lancet 393 (10191), 2599-2612, 2019
Plantar foot pressures during treadmill walking with high-heel and low-heel shoes
M Nyska, C McCabe, K Linge, L Klenerman
Foot & ankle international 17 (11), 662-666, 1996
Setting global standards for stem cell research and clinical translation: the 2016 ISSCR guidelines
GQ Daley, I Hyun, JF Apperley, RA Barker, N Benvenisty, AL Bredenoord, ...
Stem cell reports 6 (6), 787-797, 2016
Comparing breast cancer multiparameter tests in the OPTIMA prelim trial: no test is more equal than the others
J Bartlett, J Bayani, A Marshall, JA Dunn, A Campbell, C Cunningham, ...
JNCI: Journal of the National Cancer Institute 108 (9), 2016
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosisCommentary: Evaluating disease modifying treatments in …
J Chilcott, DH Miller, C McCabe, P Tappenden, A O'Hagan, NJ Cooper, ...
BMJ 326 (7388), 522, 2003
Funding the unfundable
T Stafinski, CJ McCabe, D Menon
Pharmacoeconomics 28 (2), 113-142, 2010
The system can't perform the operation now. Try again later.
Articles 1–20